摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[2-Fluoro-4-(6-nitro-3H-imidazo[4,5-b]pyridin-2-yl)-phenyl]-bis-(2-methoxy-ethyl)-amine | 896116-38-4

中文名称
——
中文别名
——
英文名称
[2-Fluoro-4-(6-nitro-3H-imidazo[4,5-b]pyridin-2-yl)-phenyl]-bis-(2-methoxy-ethyl)-amine
英文别名
[2-Fluoro-4-(6-nitro-3h-imidazo[4,5-b]pyridin-2-yl)-phenyl]-bis-(2-methoxy-ethyl)-amine;2-fluoro-N,N-bis(2-methoxyethyl)-4-(6-nitro-1H-imidazo[4,5-b]pyridin-2-yl)aniline
[2-Fluoro-4-(6-nitro-3H-imidazo[4,5-b]pyridin-2-yl)-phenyl]-bis-(2-methoxy-ethyl)-amine化学式
CAS
896116-38-4
化学式
C18H20FN5O4
mdl
——
分子量
389.386
InChiKey
MENRHYMBCZWILV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    28
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    109
  • 氢给体数:
    1
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • Benzamide Derivatives, Their Manufacture and Use as Pharmaceutical Agents
    申请人:Honold Konrad
    公开号:US20080039460A1
    公开(公告)日:2008-02-14
    Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    本发明的对象是公式I的化合物及其药学上可接受的盐、对映体形式、二对映异构体和混合物,上述化合物的制备,含有它们的药物以及其制造,以及利用上述化合物在控制或预防癌症等疾病中的用途。
  • Benzamide derivatives, their manufacture and use as pharmaceutical agents
    申请人:Hoffmann-La Roche Inc.
    公开号:US07618964B2
    公开(公告)日:2009-11-17
    Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    本发明的对象是公式I的化合物及其药学上可接受的盐、对映体、非对映异构体和混合物,上述化合物的制备,包含它们的药物和制造方法,以及上述化合物在控制或预防癌症等疾病中的使用。
  • Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
    申请人:Hoffman-La Roche Inc.
    公开号:US07786113B2
    公开(公告)日:2010-08-31
    Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    本发明的对象是公式I化合物及其药学上可接受的盐、对映体、非对映异构体和混合物,上述化合物的制备、含有它们的药物以及它们的制造,以及上述化合物在控制或预防癌症等疾病中的使用。
查看更多